CD274 and neoplasm: Thus, the investigation of the role of ICI in PM reached a turning point by exploring the co-targeting of CTLA-4 and of the PD1/PD-L1 axis, increasing the efficacy of ICI therapy and overcoming the mechanisms of resistance in tumor cells.